Department of Endocrinology, Shenzhen Children's Hospital, 7019# Yitian Road, Futian District, Shenzhen, 518038, Guangdong Province, China.
Pathology Department, Shenzhen Children's Hospital, Shenzhen, 518038, China.
BMC Endocr Disord. 2018 Nov 6;18(1):78. doi: 10.1186/s12902-018-0307-6.
Congenital lipoid adrenal hyperplasia (CLAH) is an extremely rare and the most severe form of congenital adrenal hyperplasia. Typical features include disorder of sex development, early-onset adrenal crisis and enlarged adrenal glands with fatty accumulation.
We report a case of CLAH caused by mutations in the steroidogenic acute regulatory protein (StAR) gene. The patient had typical early-onset adrenal crisis at 2 months of age. She had normal-appearing female genitalia and a karyotype of 46, XY. The serum cortisol and adrenal steroids levels were always nearly undetectable, but the adrenocorticotropic hormone levels were extremely high. Genetic analysis revealed compound heterozygous mutations at c. 229C > T (p.Q77X) in exon 3 and c. 722C > T (p.Q258X) in exon 7 of the StAR gene. The former mutation was previously detected in only two other Chinese CLAH patients. Both mutations cause truncation of the StAR protein. The case reported here appears to be a classic example of CLAH with very small adrenal glands and is the second reported CLAH case with small adrenal glands thus far. In a 15-year follow-up, the patient's height was approximately average for females before age 4 and fell to - 1 SDS at 10 years of age. Her bone age was similar to her chronological age from age 4 to age 15 years.
In conclusion, this is a classic case of CLAH with exceptionally small adrenal glands. Q77X mutation seems to be more common in Chinese CLAH patients. Additionally, this is the first report of the growth pattern associated with CLAH after a 15-year follow-up.
先天性脂质性肾上腺增生症(CLAH)是一种极其罕见的,也是最严重的先天性肾上腺增生症形式。其典型特征包括性发育障碍、早发性肾上腺危象和增大的肾上腺伴脂肪堆积。
我们报告了一例由类固醇急性调节蛋白(StAR)基因突变引起的 CLAH 病例。该患者在 2 个月大时即出现典型的早发性肾上腺危象。她的女性外生殖器外观正常,核型为 46,XY。血清皮质醇和肾上腺类固醇水平几乎无法检测到,但促肾上腺皮质激素水平极高。基因分析显示 StAR 基因外显子 3 的 c.229C>T(p.Q77X)和外显子 7 的 c.722C>T(p.Q258X)复合杂合突变。前者突变此前仅在另外两名中国 CLAH 患者中发现过。这两种突变均导致 StAR 蛋白的截断。本例似乎是典型的小肾上腺 CLAH 病例,是迄今为止报告的第二例小肾上腺 CLAH 病例。在 15 年的随访中,患者的身高在 4 岁前接近女性平均水平,在 10 岁时降至-1 SDS。她的骨龄与 4 至 15 岁的实际年龄相似。
总之,这是一例具有非常小的肾上腺的典型 CLAH 病例。Q77X 突变似乎在中国 CLAH 患者中更为常见。此外,这是首例在 15 年随访后报告的与 CLAH 相关的生长模式的病例。